CY1111250T1 - Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων - Google Patents
Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντωνInfo
- Publication number
- CY1111250T1 CY1111250T1 CY20111100060T CY111100060T CY1111250T1 CY 1111250 T1 CY1111250 T1 CY 1111250T1 CY 20111100060 T CY20111100060 T CY 20111100060T CY 111100060 T CY111100060 T CY 111100060T CY 1111250 T1 CY1111250 T1 CY 1111250T1
- Authority
- CY
- Cyprus
- Prior art keywords
- group
- hydrogen atom
- ring
- atom
- bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D515/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Dental Preparations (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση αφορά τα παράγωγα του βενζοπυρανίου του τύπου (I) ή (II), ή φαρμακευτικά αποδεχτά άλατα σχετικά με αυτά όπου τα R1 και R2 είναι, ανεξάρτητα το ένα από το άλλο, άτομο υδρογόνου, C1-6 αλκυλομάδα ή C6-14 αρυλομάδα, το R3 είναι άτομο υδρογόνου ή C1-6 αλκυλοκαρβονυλοξυομάδα ή σχηματίζει ένα δεσμό μαζί με το R4, το R4 είναι άτομο υδρογόνου ή σχηματίζει ένα δεσμό μαζί με το R3, το «m» είναι ένας ακέραιος αριθμός από το 0-4, το «n» είναι ένας ακέραιος αριθμός από το 0-4, το «V» είναι ένας μονός δεσμός, CR7R8, NR9, Ο, S, SO ή SO2, το R5 είναι άτομο υδρογόνου ή C1-6 αλκυλομάδα, το R6 είναι άτομο υδρογόνου, C1-6 αλκυλομάδα, C3-8 κυκλοαλκυλομάδα, C3-8 κυκλοαλκενυλομάδα, αμινομάδα, C1-6 αλκυλαμινομάδα, δι- C1-6, αλκυλαμινομάδα, C6-14 αρυλαμινομάδα, C2-9 ετεροαρυλαμινομάδα, C6-14 αρυλομάδα, C2-9 ετεροαρυλομάδα ή C2-9 ετεροκυκλυλομάδα, το Α είναι 5-μελής, 6-μελής ή 7-μελής δακτύλιος συζευγμένος με δακτύλιο βενζολίου, ως συστατικό άτομο του δακτυλίου, το άτομο οξυγόνου, το άτομο αζώτου, ή το άτομο θείου μπορεί να περιλαμβάνονται στον αριθμό 1 έως 3 μόνα τους ή σε συνδυασμό σχετικά με αυτά, ο αριθμός του ακόρεστου δεσμού στο δακτύλιο είναι 1, 2 ή 3 συμπεριλαμβανομένου ενός ακόρεστου δεσμού του δακτυλίου του βενζολίου για σύζευξη, τα άτομα άνθρακα που αποτελούν το δακτύλιο μπορεί να είναι καρβονυλικά ή θειοκαρβονυλικά. Οι παρούσες ενώσεις είναι χρήσιμες ως ένας αντιαρρυθμικός παράγοντας.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004084605 | 2004-03-23 | ||
EP05727581A EP1732929B1 (en) | 2004-03-23 | 2005-03-23 | Tricyclic benzopyran compound as anti-arrhythmic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111250T1 true CY1111250T1 (el) | 2015-06-11 |
Family
ID=34962589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100060T CY1111250T1 (el) | 2004-03-23 | 2011-01-19 | Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων |
Country Status (31)
Country | Link |
---|---|
US (2) | US7652008B2 (el) |
EP (1) | EP1732929B1 (el) |
JP (1) | JP4840594B2 (el) |
KR (2) | KR101019402B1 (el) |
CN (3) | CN1934116B (el) |
AT (1) | ATE485299T1 (el) |
AU (2) | AU2005223612B2 (el) |
BR (1) | BRPI0508768A (el) |
CA (1) | CA2558139C (el) |
CY (1) | CY1111250T1 (el) |
CZ (1) | CZ2006598A3 (el) |
DE (1) | DE602005024245D1 (el) |
DK (1) | DK1732929T3 (el) |
EG (1) | EG27163A (el) |
ES (1) | ES2353021T3 (el) |
HK (1) | HK1099299A1 (el) |
HR (1) | HRP20110005T1 (el) |
IL (1) | IL177950A (el) |
MX (1) | MXPA06010880A (el) |
NO (1) | NO339495B1 (el) |
NZ (2) | NZ585606A (el) |
PL (1) | PL1732929T3 (el) |
PT (1) | PT1732929E (el) |
RS (1) | RS51742B (el) |
RU (1) | RU2380370C2 (el) |
SI (1) | SI1732929T1 (el) |
SK (1) | SK287994B6 (el) |
TW (1) | TWI352704B (el) |
UA (1) | UA91189C2 (el) |
WO (1) | WO2005090357A1 (el) |
ZA (1) | ZA200607388B (el) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005024245D1 (de) * | 2004-03-23 | 2010-12-02 | Nissan Chemical Ind Ltd | Tricyclische benzopyranverbindungen als antiarrhythmika |
AU2007225765B2 (en) | 2006-03-10 | 2012-05-24 | Nissan Chemical Industries, Ltd. | Process for producing optically active chromene oxide compound |
WO2010018867A1 (ja) * | 2008-08-14 | 2010-02-18 | 日産化学工業株式会社 | ジ置換ベンゾピラン化合物 |
CN102414213B (zh) | 2009-04-30 | 2014-12-24 | 日产化学工业株式会社 | 三环苯并吡喃化合物的新的晶形及其制造方法 |
EP3309151A1 (en) * | 2009-06-25 | 2018-04-18 | Alkermes Pharma Ireland Limited | Heterocyclic compounds for the treatment of neurological and psychological disorders |
JP6202280B2 (ja) * | 2012-09-27 | 2017-09-27 | 日産化学工業株式会社 | 含窒素複素環n−オキシド化合物の製造方法 |
WO2014051077A1 (ja) * | 2012-09-27 | 2014-04-03 | 日産化学工業株式会社 | 高純度の含窒素複素環化合物の製造方法 |
JPWO2015012271A1 (ja) * | 2013-07-25 | 2017-03-02 | 日産化学工業株式会社 | 複素環化合物の製造方法 |
EP3567044A4 (en) | 2017-01-06 | 2020-06-10 | Korea University Research and Business Foundation, Sejong Campus | INNOVATIVE CHINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALLERGIC DISEASES LIKE ASTHMA OR ATOPIA THEREFORE AS AN ACTIVE SUBSTANCE |
AU2019230014A1 (en) | 2018-03-05 | 2020-09-17 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
CN108727261B (zh) * | 2018-06-21 | 2021-09-24 | 济南大学 | 一种硝基取代喹那啶的制备方法 |
WO2020138428A1 (ja) * | 2018-12-28 | 2020-07-02 | 国立大学法人大阪大学 | 遺伝性徐脈性不整脈治療薬 |
RU2754610C1 (ru) * | 2020-04-14 | 2021-09-03 | Георгий Викторович ТЕЦ | Препарат для лечения заболеваний, вызванных бактериями |
TW202214582A (zh) * | 2020-06-26 | 2022-04-16 | 國立大學法人大阪大學 | 藥劑誘發性心律過慢及心律過慢性心律不整治療藥 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZM7682A1 (en) | 1981-09-25 | 1983-05-23 | Beecham Group Plc | Active compounds |
JPS5867683U (ja) | 1981-10-28 | 1983-05-09 | 株式会社ナムコ | 歩行ロボツト |
JPH0699439B2 (ja) | 1988-02-03 | 1994-12-07 | 日産化学工業株式会社 | ピラノベンゾオキサジアゾール誘導体 |
JP2658198B2 (ja) * | 1988-06-23 | 1997-09-30 | 日産化学工業株式会社 | ピラノベンゾトリアゾール誘導体 |
JP2876712B2 (ja) * | 1989-07-17 | 1999-03-31 | 日産化学工業株式会社 | 光学活性ピラノベンゾオキサジアゾール誘導体 |
US5097037A (en) | 1989-07-17 | 1992-03-17 | Nissan Chemical Industries, Ltd. | Process for the optical resolution of pyranobenzoxadiazole compounds |
US5164509A (en) | 1990-11-26 | 1992-11-17 | E. R. Squibb & Sons, Inc. | Benzodiazolo analogs |
JPH07300414A (ja) * | 1993-04-02 | 1995-11-14 | Nissan Chem Ind Ltd | 心不全治療薬 |
AU677643B2 (en) | 1993-04-02 | 1997-05-01 | Nissan Chemical Industries Ltd. | Heart failure remedy |
JP2734457B2 (ja) | 1994-02-23 | 1998-03-30 | 日産化学工業株式会社 | 不斉エポキシ化反応 |
DE69518322T2 (de) | 1994-06-10 | 2001-02-15 | Smithkline Beecham Plc | C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel |
TW496866B (en) * | 1996-05-15 | 2002-08-01 | Hoechst Ag | Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or a diagnostic, and medicament comprising them |
CA2334412A1 (en) | 1998-06-03 | 1999-12-09 | Nissan Chemical Industries, Ltd. | Indan derivatives |
AU5444499A (en) | 1998-09-01 | 2000-03-21 | Nissan Chemical Industries Ltd. | Benzoxazine derivatives |
WO2000058300A1 (fr) | 1999-03-25 | 2000-10-05 | Nissan Chemical Industries, Ltd. | Derives du chroman |
SK3292002A3 (en) | 1999-09-17 | 2003-04-01 | Nissan Chemical Ind Ltd | Benzopyran derivative |
US6555574B1 (en) | 1999-09-24 | 2003-04-29 | Nissan Chemical Industries, Ltd. | 4-oxybenzopyran derivative |
AU7453900A (en) | 1999-10-05 | 2001-05-10 | Nissan Chemical Industries Ltd. | 4-oxybenzopyran derivative |
TW589305B (en) | 2001-02-14 | 2004-06-01 | Nissan Chemical Ind Ltd | 4-aminobenzopyran derivatives |
CN1279036C (zh) | 2001-06-25 | 2006-10-11 | 日产化学工业株式会社 | 抗心律失常的取代的苯并吡喃衍生物 |
WO2003014113A1 (en) | 2001-08-06 | 2003-02-20 | Glenmark Pharmaceuticals Limited | Novel benzopyran compounds and process for their preparation and use |
DE602005024245D1 (de) * | 2004-03-23 | 2010-12-02 | Nissan Chemical Ind Ltd | Tricyclische benzopyranverbindungen als antiarrhythmika |
-
2005
- 2005-03-23 DE DE602005024245T patent/DE602005024245D1/de active Active
- 2005-03-23 BR BRPI0508768-6A patent/BRPI0508768A/pt not_active Application Discontinuation
- 2005-03-23 CA CA2558139A patent/CA2558139C/en not_active Expired - Fee Related
- 2005-03-23 CN CN2005800090295A patent/CN1934116B/zh active Active
- 2005-03-23 RS RS20110028A patent/RS51742B/en unknown
- 2005-03-23 WO PCT/JP2005/006004 patent/WO2005090357A1/en active Application Filing
- 2005-03-23 CN CN2011100751168A patent/CN102190661B/zh not_active Expired - Fee Related
- 2005-03-23 JP JP2006530022A patent/JP4840594B2/ja active Active
- 2005-03-23 KR KR1020067021988A patent/KR101019402B1/ko active IP Right Grant
- 2005-03-23 CN CN2008101707921A patent/CN101429200B/zh not_active Expired - Fee Related
- 2005-03-23 KR KR1020107027058A patent/KR101085979B1/ko active IP Right Grant
- 2005-03-23 EP EP05727581A patent/EP1732929B1/en active Active
- 2005-03-23 SK SK5079-2006A patent/SK287994B6/sk not_active IP Right Cessation
- 2005-03-23 TW TW094108962A patent/TWI352704B/zh active
- 2005-03-23 DK DK05727581.0T patent/DK1732929T3/da active
- 2005-03-23 NZ NZ585606A patent/NZ585606A/en unknown
- 2005-03-23 ES ES05727581T patent/ES2353021T3/es active Active
- 2005-03-23 US US10/590,975 patent/US7652008B2/en active Active
- 2005-03-23 ZA ZA200607388A patent/ZA200607388B/en unknown
- 2005-03-23 AU AU2005223612A patent/AU2005223612B2/en not_active Ceased
- 2005-03-23 UA UAA200611101A patent/UA91189C2/ru unknown
- 2005-03-23 CZ CZ20060598A patent/CZ2006598A3/cs unknown
- 2005-03-23 SI SI200531171T patent/SI1732929T1/sl unknown
- 2005-03-23 NZ NZ549570A patent/NZ549570A/en unknown
- 2005-03-23 PL PL05727581T patent/PL1732929T3/pl unknown
- 2005-03-23 RU RU2006137284/04A patent/RU2380370C2/ru not_active IP Right Cessation
- 2005-03-23 PT PT05727581T patent/PT1732929E/pt unknown
- 2005-03-23 AT AT05727581T patent/ATE485299T1/de active
- 2005-03-23 MX MXPA06010880A patent/MXPA06010880A/es active IP Right Grant
-
2006
- 2006-09-02 EG EGNA2006000900 patent/EG27163A/xx active
- 2006-09-07 IL IL177950A patent/IL177950A/en not_active IP Right Cessation
- 2006-10-23 NO NO20064819A patent/NO339495B1/no not_active IP Right Cessation
-
2007
- 2007-06-15 HK HK07106502.1A patent/HK1099299A1/xx unknown
-
2009
- 2009-11-17 US US12/591,353 patent/US7964623B2/en not_active Expired - Fee Related
-
2010
- 2010-07-08 AU AU2010202900A patent/AU2010202900B2/en not_active Ceased
-
2011
- 2011-01-05 HR HR20110005T patent/HRP20110005T1/hr unknown
- 2011-01-19 CY CY20111100060T patent/CY1111250T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111250T1 (el) | Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων | |
BG107120A (en) | Novel, slow-acting betamimetics, a method for their production and their use as medicaments | |
MY139988A (en) | Macrocylic inhibitors of hepatitis c virus | |
MY127144A (en) | New anticholinergics which may be used as medicaments as well as processes for preparing them | |
HUP0202799A2 (hu) | Herbicid hatású izoxazolinszármazékok és azt tartalmazó készítmény | |
MX9504287A (es) | Derivados de camptotecina y proceso para su preparacion. | |
CY1109222T1 (el) | Παραγωγο συγχωνευμενης κινολινης και χρηση του | |
AP2003002841A0 (en) | Quinazolines as MMP-13 inhibitors | |
EP1719761A4 (en) | NEW HETEROCYCLIC CONNECTION | |
NZ505927A (en) | Cyclobutene-1,2-dione derivatives for use in the inhibition of an ileal bile acid transporter | |
HUP0203839A2 (hu) | 4-Fenil-1-piperazinil-, -piperidinil- és tetrahidropiridil-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ES2073258T3 (es) | Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica. | |
NZ245783A (en) | Benzopyran and dibenzopyran derivatives as intermediates | |
MXPA02007973A (es) | Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece. | |
EP0999211A4 (en) | PURINE DERIVATIVES AND THEIR MEDICINAL APPLICATION | |
IL136510A (en) | Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same | |
CA2440186A1 (en) | Medicinal composition containing 1,3-thiazine derivative | |
WO1999005165A8 (fr) | Derives de streptogramines, leur preparation et les compositions qui les contiennent | |
DK1546096T3 (da) | Fremgangsmåde til fremstilling af aminopyrrolidinderivater | |
AR034088A1 (es) | Composicion que comprende derivados anticonvulsivantes utiles en el tratamiento de esquizofrenia y el uso de dicho derivado para la manufactura de un medicamento | |
DE60239491D1 (de) | Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung | |
UY26245A1 (es) | Nuevos derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen art 127 de la ley 17164 | |
TH61861A3 (th) | 4-ออกโซ-1,4-ไดไฮโดร-3-ควิโนลีนคาร์บอกซามีดที่เป็นตัวกระทำต้านเชื้อไวรัส | |
ECSP992984A (es) | Derivados de isotiazol utiles como agentes anticancerosos | |
TH25178B (th) | สารประกอบประเภทใหม่ |